Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Key Information
Due Date: December 23, 2027
Agency: Not Specified
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: Not Specified
Funding Type: Grant, Government
Match Required: No
Status: Posted
Contact Info:
National Institutes of Health
grantsinfo@nih.gov
NIH Grants Information
grantsinfo@nih.gov
301-402-2541
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
needed for the activities required to identify and characterize potential therapeutic candidates and combination products to treat HLBS diseases and disorders. This initiative has a companion initiative that supports development of devices and diagnostics and is also part of a suite of innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Preclinical Program.
Key Dates
Open Date: Not Specified
Application Due Date: December 23, 2027
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- City or township governments
- Small businesses
- Native American tribal governments (Federally recognized)
- Public and State controlled institutions of higher education
- Others
- State governments
- Special district governments
- For profit organizations other than small businesses
- Independent school districts
- Native American tribal organizations (other than Federally recognized tribal governments)
- Public housing authorities/Indian housing authorities
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- County governments